- Home
- AXIL vs BRNS Comparison
AXIL vs BRNS Comparison
Compare AXIL & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXIL
- BRNS
- Stock Information
- Founded
- AXIL 2015
- BRNS 2016
- Country
- AXIL United States
- BRNS United Kingdom
- Employees
- AXIL N/A
- BRNS N/A
- Industry
- AXIL Package Goods/Cosmetics
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- AXIL Consumer Discretionary
- BRNS Health Care
- Exchange
- AXIL Nasdaq
- BRNS Nasdaq
- Market Cap
- AXIL 36.5M
- BRNS 36.0M
- IPO Year
- AXIL N/A
- BRNS 2021
- Fundamental
- Price
- AXIL $4.94
- BRNS $1.00
- Analyst Decision
- AXIL
- BRNS Strong Buy
- Analyst Count
- AXIL 0
- BRNS 1
- Target Price
- AXIL N/A
- BRNS $3.00
- AVG Volume (30 Days)
- AXIL 14.9K
- BRNS 11.5K
- Earning Date
- AXIL 08-14-2025
- BRNS 08-07-2025
- Dividend Yield
- AXIL N/A
- BRNS N/A
- EPS Growth
- AXIL 93.65
- BRNS N/A
- EPS
- AXIL 0.29
- BRNS N/A
- Revenue
- AXIL $27,007,463.00
- BRNS $14,969,000.00
- Revenue This Year
- AXIL N/A
- BRNS N/A
- Revenue Next Year
- AXIL N/A
- BRNS N/A
- P/E Ratio
- AXIL $17.14
- BRNS N/A
- Revenue Growth
- AXIL N/A
- BRNS 4381.74
- 52 Week Low
- AXIL $3.54
- BRNS $0.64
- 52 Week High
- AXIL $10.75
- BRNS $1.58
- Technical
- Relative Strength Index (RSI)
- AXIL 38.20
- BRNS 53.30
- Support Level
- AXIL $5.02
- BRNS $0.90
- Resistance Level
- AXIL $5.70
- BRNS $0.94
- Average True Range (ATR)
- AXIL 0.56
- BRNS 0.05
- MACD
- AXIL -0.03
- BRNS 0.00
- Stochastic Oscillator
- AXIL 7.75
- BRNS 96.80
About AXIL AXIL Brands Inc. Common Stock
AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.